1. Nankivell, B. J., & Kuypers, D. R. (2011). Diagnosis and prevention of chronic kidney allograft loss. Lancet, 378(9800), 1428–1437.
2. O’Connell, P. J., Zhang, W., Menon, M. C., Yi, Z., Schroppel, B., Gallon, L., Luan, Y., Rosales, I. A., Ge, Y., Losic, B., et al. (2016). Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study. Lancet, 388(10048), 983–993.
3. Chapman, J. R., O’Connell, P. J., & Nankivell, B. J. (2005). Chronic renal allograft dysfunction. Journal of the American Society of Nephrology : JASN, 16(10), 3015–3026.
4. Elseweidy, M. M., Askar, M. E., Elswefy, S. E., & Shawky, M. (2018). Nephrotoxicity induced by cisplatin intake in experimental rats and therapeutic approach of using mesenchymal stem cells and spironolactone. Applied Biochemistry and Biotechnology, 184(4), 1390–1403.
5. Modena, B. D., Kurian, S. M., Gaber, L. W., Waalen, J., Su, A. I., Gelbart, T., Mondala, T. S., Head, S. R., Papp, S., Heilman, R., et al. (1982-1998). Gene expression in biopsies of acute rejection and interstitial fibrosis/tubular atrophy reveals highly shared mechanisms that correlate with worse long-term outcomes. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2016, 16.